ISOperistaltic Versus ANTIperistaltic Anastomosis After Laparoscopic Right Colectomy for Cancer
Launched by HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA · Dec 3, 2014
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient has given informed consent to participate
- • No surgery contraindications
- • Elective surgery
- • No pregnancy or nursery during the study
- • Older than 18 years
- • Complete preoperative cancer staging
- * Tumour characteristics:
- • Cecum, ascending, hepatic angle or transverse colon tumour confirmed by endoscopic biopsy
- • Radiologically resectable tumours
- • Absence of vascular, nervous or bone infiltration
- • T4 stages with near organ infiltration
- • Absence of peritoneal carcinomatosis
- • Absence of respiratory pathology that prevents for doing hydrogen breath test
- Exclusion Criteria:
- • Pregnancy
- • Intestinal bowel disease like Crohn's disease or ulcerative colitis.
- • Metastatic bone illness
- • Previous abdominal surgery with bowel resection
- • Malabsorption syndromes
About Hospital Universitario Virgen De La Arrixaca
Hospital Universitario Virgen de la Arrixaca, located in Murcia, Spain, is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. As a prominent institution in the field of medicine, it integrates cutting-edge technology and a multidisciplinary approach to patient care. The hospital is committed to improving treatment outcomes and enhancing patient safety, actively participating in a wide range of clinical studies aimed at evaluating new therapies and medical interventions. With a strong emphasis on collaboration and excellence, Hospital Universitario Virgen de la Arrixaca plays a vital role in the development of evidence-based practices in the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murcia, , Spain
Patients applied
Trial Officials
Juan Lujan, Ph D
Study Director
Hospital Universitario Virgen de la Arrixaca
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials